Here's your Cheat Sheet to earnings...

HCA Holdings Inc., the largest for- profit U.S. hospital chain, reported first-quarter profit that fell short of analysts’ estimates.

Abbott has performed well since the spinoff. Is this trend likely to continue?

Opko's Next Acquisition?

Impax's first quarter 2013 adjusted earnings of 37 cents per share were above the Zacks Consensus Estimate of 23 cents.

DUBLIN (Reuters) - Royalty Pharma ROYPH.UL submitted its $11.25 per share bid for Elan (ELN.I: Quote , Profile , Research , Stock Buzz )(ELN.N: Quote , Profile , Research , Stock Buzz ) to the Irish drugmaker's ...

JERUSALEM, May 2 (Reuters) - Teva Pharmaceutical Industries , the world's largest generic drugmaker, expects U.S. regulators to act on its more convenient three-times-a-week dosing regimen of multiple ...

Here are some top Healthcare stock stories for the afternoon: 3 Healthcare Stock Stories For Midweek Wellness

If you're uninsured, getting on Medicaid clearly improves your mental health, but it doesn't seem to make much difference in physical conditions such as high blood pressure. The counterintuitive findings ...

May 2 (Reuters) - Teva Pharmaceutical Industries Chief Financial Officer Eyal Desheh says: * Reiterates 2013 revenue forecast $19.5-$20.5 bln, adjusted EPS $4.85-$5.15 (Reporting by Tova Cohen)

Novo Nordisk reported first quarter 2013 earnings of $1.94 per ADR, up 32.5% from the year-ago period

After Allergan announced that it would conduct additional studies on two drugs in its pipeline, significantly delaying commercialization of the products, Wells Fargo expects the stock to be supported by ...

Here's your Cheat Sheet to earnings...

* First qtr adj EPS $1.99 vs est $1.86 * First qtr rev $1.90 bln vs $1.97 bln * Raises 2013 adj EPS outlook to $8.10-$8.50 from $7.70-$8.10 May 2 (Reuters) - Generic drugmaker Actavis Inc, formerly Watson ...

Here's your Cheat Sheet to earnings...

StemCells Inc: CEO Martin McGlynn Is Building A Blockbuster Company

Atossa Genetics Novel Test Could Generate Nice Profits

Pfizer's Efforts Boost Pain Therapeutics And Durect Corp.

Four Tech Stocks With Top Long-Term Earnings Growth

WINNIPEG, Manitoba, May 2 (Reuters) - Valeant Pharmaceuticals International Inc Chief Executive Michael Pearson said on Thursday that the company would focus on acquisitions with strong cash flow in high ...

St. Jude Medical announced first enrollment of its MultiPoint Pacing clinical study to build upon its first- to-market Quadripolar Pacing System. Patients will be implanted with the Quadra Assura MP cardiac ...

Join TheStreet's Adam Feuerstein as he live blogs FDA advisory panels for Aveo Oncology and Delcath Systems

Santarus announced the inclusion of Cycloset (bromocriptine mesylate) as a therapy for patients with type 2 diabetes in a new comprehensive diabetes management algorithm published by the American Association ...

TEL AVIV, May 2 (Reuters) - Teva Pharmaceutical Industries posted lower first-quarter profit as its revenue in the United States was hurt by a drop in sales of a key product due to generic competition. ...

Royalty Pharma has issued an offer document that confirms the offer price of $1B Dutch Auction share repurchase clearing price of $11.25 per Elan Share. Royalty Pharma believes this clearing price validates ...

May 2 (Reuters) - Generic drugmaker Actavis Inc, formerly known as Watson Pharmaceuticals, reported an adjusted quarterly profit that beat market estimates, helped by new products, and the company raised ...

Teva Pharmaceutical Industries Ltd.’s first-quarter profit fell 26 percent as a branded drug lost patent protection and opportunities diminished to introduce new generic medicines.

Here's your Cheat Sheet to earnings...

Here's your Cheat Sheet to earnings...

AVEO Oncology announced that NASDAQ halted trading of AVEO common stock this morning, May 2, 2013. The U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee meets today to discuss the ...

The biotech sector as a whole has been outperforming the S&P by a considerable percentage, but one stock overall stands out as a must-buy for investors. However, does it still have room to run?

07:00 EDT Aveo Pharmaceuticals trading halted, pending news

May 2 (Reuters) - Cigna Corp on Thursday reported a 39 percent rise in first-quarter earnings, beating analysts' expectations, as the insurer benefited from its acquisition of Medicare specialist HealthSpring ...

Lpath: The Leader In Lipidomics

May 2 (Reuters) - Cigna Corp said on Thursday that its first-quarter profit rose 39 percent, excluding a previously announced charge, and revenue increased 21 percent. Excluding the charge from a deal ...

May 2 (Reuters) - Valeant Pharmaceuticals International Inc , Canada's biggest publicly traded drugmaker, reported a bigger first-quarter loss as expenses rose due to its $2.6 billion acquisition of Medicis ...

Symphogen A/S, a closely held Danish biotechnology company, raised 141 million euros ($186 million) from existing investors to develop its experimental cancer treatments.

06:02 EDT Cigna reports global customer base grew by 277,000 in Q1

Genmab A/S rose the most in almost two months in Copenhagen trading after U.S. regulators granted “breakthrough therapy” designation to an experimental cancer drug the Danish company is developing with ...

Zealand Pharma A/S, the Danish drugmaker, rose the most in seven weeks in Copenhagen trading after partner Sanofi said it will step up commitment to develop diabetes treatment Lyxumia as a rival drug faces ...

Merge Healthcare (Nasdaq:MRGE) has been upgraded by TheStreet Ratings from a sell to hold.

For three years, an incredibly nerdy—but consequential—debate has raged among health policy researchers regarding Medicaid, America’s government-run health-care program for the poor. Piles of studies have shown that people on Medicaid have health outcomes that are no better, and often worse, than those with no insurance …

The Obama administration's decision to appeal a court order lifting age limits on purchasers of the morning-after pill set off a storm of criticism from reproductive rights groups, who denounced it as ...

By Maggie Lu Yueyang SYDNEY, May 2 (Reuters) - Ramsay Health Care Ltd, Australia's largest private hospital operator, is in talks to invest in China's private healthcare market, banking on increasing demand ...

French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings. Sanofi's net profit ...

Sanofi, France’s largest drugmaker, reported a 34 percent decline in first-quarter profit, crimped by generic competition to three key medicines in the U.S.

Why Did Pain Therapeutics Increase Over 25%?

Johnson & Johnson: Blue Chip Chaser Vs. The Value Hunter